Ewa Pocheć Selected Research

Integrin alpha3beta1

12/2008	Characterisation of alpha3beta1 and alpha(v)beta3 integrin N-oligosaccharides in metastatic melanoma WM9 and WM239 cell lines.
1/2006	Characterization of the oligosaccharide component of alpha3beta1 integrin from human bladder carcinoma cell line T24 and its role in adhesion and migration.
12/2003	Glycosylation profile of integrin alpha 3 beta 1 changes with melanoma progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ewa Pocheć Research Topics

Disease

14	Melanoma (Melanoma, Malignant) 04/2016 - 12/2003
10	Neoplasms (Cancer) 01/2017 - 01/2002
7	Inflammation (Inflammations) 01/2022 - 04/2016
4	Thyroiditis 01/2022 - 01/2020
3	Thyroid Diseases (Thyroid Disease) 01/2022 - 01/2020
3	Carcinogenesis 09/2018 - 12/2013
2	Graves Disease (Basedow Disease) 01/2022 - 01/2019
2	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 01/2019
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2017 - 12/2016
2	Obesity 06/2017 - 12/2016
2	Insulin Resistance 06/2017 - 12/2016
2	Pathologic Processes 01/2015 - 12/2008
2	Wounds and Injuries (Trauma) 03/2008 - 01/2006
1	Hypothyroidism 01/2022
1	Rheumatoid Arthritis 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021
1	Multiple Sclerosis 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Chronic Disease (Chronic Diseases) 09/2018
1	Thyroid Neoplasms (Thyroid Cancer) 09/2018
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Diabetes Mellitus 12/2016
1	Arteriosclerosis 12/2016
1	Skin Neoplasms (Skin Cancer) 04/2016
1	Peritonitis 04/2016
1	Breast Neoplasms (Breast Cancer) 09/2009
1	Uveal melanoma 03/2008
1	Carcinoma (Carcinomatosis) 01/2006

Drug/Important Bio-Agent (IBA)

18	Polysaccharides (Glycans)IBA 01/2022 - 12/2003
8	IntegrinsIBA 01/2016 - 01/2002
7	OligosaccharidesIBA 12/2013 - 01/2006
5	Immunoglobulin G (IgG)IBA 01/2022 - 01/2020
5	Fibronectins (Fibronectin)IBA 12/2013 - 01/2002
5	Glycoproteins (Glycoprotein)IBA 01/2010 - 01/2006
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2002
4	VitronectinIBA 01/2016 - 12/2008
3	AntibodiesIBA 01/2020 - 01/2002
3	Riboflavin (Vitamin B2)FDA LinkGeneric 06/2017 - 04/2016
3	N-Acetylneuraminic Acid (Sialic Acid)IBA 04/2015 - 01/2002
3	alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferaseIBA 01/2015 - 01/2006
3	Integrin alpha3beta1IBA 12/2008 - 12/2003
2	AutoantibodiesIBA 01/2022 - 01/2020
2	CytokinesIBA 08/2019 - 06/2017
2	EnzymesIBA 04/2015 - 12/2013
2	SwainsonineIBA 04/2015 - 01/2006
2	LectinsIBA 04/2015 - 04/2013
2	plants leukoagglutininsIBA 04/2015 - 09/2007
2	Peptides (Polypeptides)IBA 09/2009 - 01/2006
2	Mannosyl-Glycoprotein Endo-beta-N-AcetylglucosaminidaseIBA 01/2006 - 12/2003
2	CollagenIBA 01/2006 - 01/2002
2	Laminin (Merosin)IBA 01/2006 - 01/2002
1	Methimazole (Thiamazole)FDA LinkGeneric 01/2022
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 01/2022
1	anti-thyroglobulinIBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2020
1	Iodide Peroxidase (Deiodinase)IBA 01/2020
1	Blood Proteins (Serum Proteins)IBA 01/2020
1	AutoantigensIBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2017
1	GlycoconjugatesIBA 01/2017
1	LipopolysaccharidesIBA 12/2016
1	ZymosanIBA 04/2016
1	Complementary DNA (cDNA)IBA 04/2016
1	HMGB1 Protein (HMG1)IBA 04/2016
1	Cisplatin (Platino)FDA LinkGeneric 04/2016
1	Tyrosine (L-Tyrosine)FDA Link 01/2016
1	AgglutininsIBA 04/2015
1	PhytohemagglutininsIBA 04/2015
1	AcetylglucosamineIBA 08/2014
1	N-AcetylglucosaminyltransferasesIBA 08/2014
1	Membrane Proteins (Integral Membrane Proteins)IBA 12/2013
1	Cell Surface ReceptorsIBA 12/2013
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 04/2013
1	Glycoside Hydrolases (Endoglycosidases)IBA 04/2013
1	EpitopesIBA 04/2013
1	Integrin alphaVbeta3IBA 01/2010
1	NucleolinIBA 09/2009
1	polyacrylamideIBA 09/2009
1	Vicia lectinsIBA 09/2009
1	KalininIBA 12/2008
1	Integrin beta3 (GPIIIa)IBA 12/2008
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 03/2008
1	Fibronectin ReceptorsIBA 03/2008
1	Carrier Proteins (Binding Protein)IBA 09/2007
1	chondroitin sulfate proteoglycan 4IBA 09/2007
1	Cell Adhesion MoleculesIBA 09/2007
1	Lysosomal Membrane ProteinsIBA 09/2007
1	AntigensIBA 09/2007
1	Sepharose (Agarose)IBA 09/2007
1	CD146 AntigenIBA 09/2007
1	Extracellular Matrix ProteinsIBA 01/2006
1	CarbohydratesIBA 12/2003
1	LigandsIBA 12/2003
1	Integrin alpha3IBA 01/2002

Therapy/Procedure

3	Lasers (Laser) 04/2013 - 12/2003
2	Therapeutics 01/2022 - 04/2016
1	Intraperitoneal Injections 04/2016